Acid-related disorders in the elderly

Marilisa Franceschi, Francesco Di Mario, Gioacchino Leandro, Stefania Maggi, Alberto Pilotto

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Diseases of the upper gastrointestinal tract such as gastroesophageal reflux disease (GERD), peptic ulcer and gastric cancer become more common and more severe with advancing age. Older individuals also tend to have a higher prevalence of co-morbid factors, such as Helicobacter pylori infection, presence of other diseases, or use of medications (e.g., nonsteroidal anti-inflammatory drugs, bisphosphonates) that increase their risk for acid-related disorders. Unfortunately, in the elderly patient with these disorders symptom presentation may be slight or atypical, resulting in a delayed diagnosis. In general, the treatment of older individuals with peptic ulcer or GERD and its complications is similar to that of younger individuals. Proton pump inhibitors are the basis of therapy for symptom relief, healing of erosive esophagitis and peptic ulceration, reduction of the risk for NSAID induced mucosal damage, and prevention of disease relapses. The strongest prevalence of H.pylori infection in the elderly, as well as the role of H.pylori in the occurrence of gastric lesions, in particular ulcer diseases, gastric precancerous lesions and gastric cancer, make the diagnosis and the eradication of H.pylori in this population of the utmost importance. Strategies to improve the management of upper gastrointestinal diseases in older people will reduce mortality and improve quality of life.

Original languageEnglish
Pages (from-to)839-848
Number of pages10
JournalBailliere's Best Practice and Research in Clinical Gastroenterology
Volume23
Issue number6
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Pylorus
Gastroesophageal Reflux
Peptic Ulcer
Stomach Neoplasms
Acids
Stomach Diseases
Peptic Esophagitis
Upper Gastrointestinal Tract
Proton Pump Inhibitors
Gastrointestinal Diseases
Delayed Diagnosis
Diphosphonates
Helicobacter Infections
Non-Steroidal Anti-Inflammatory Agents
Risk Reduction Behavior
Stomach Ulcer
Secondary Prevention
Helicobacter pylori
Stomach
Anti-Inflammatory Agents

Keywords

  • elderly
  • gastroesophageal reflux disease
  • Helicobacter pylori
  • peptic ulcer
  • therapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Acid-related disorders in the elderly. / Franceschi, Marilisa; Di Mario, Francesco; Leandro, Gioacchino; Maggi, Stefania; Pilotto, Alberto.

In: Bailliere's Best Practice and Research in Clinical Gastroenterology, Vol. 23, No. 6, 12.2009, p. 839-848.

Research output: Contribution to journalArticle

Franceschi, Marilisa ; Di Mario, Francesco ; Leandro, Gioacchino ; Maggi, Stefania ; Pilotto, Alberto. / Acid-related disorders in the elderly. In: Bailliere's Best Practice and Research in Clinical Gastroenterology. 2009 ; Vol. 23, No. 6. pp. 839-848.
@article{ee6667e572ad480384e311315c324bc8,
title = "Acid-related disorders in the elderly",
abstract = "Diseases of the upper gastrointestinal tract such as gastroesophageal reflux disease (GERD), peptic ulcer and gastric cancer become more common and more severe with advancing age. Older individuals also tend to have a higher prevalence of co-morbid factors, such as Helicobacter pylori infection, presence of other diseases, or use of medications (e.g., nonsteroidal anti-inflammatory drugs, bisphosphonates) that increase their risk for acid-related disorders. Unfortunately, in the elderly patient with these disorders symptom presentation may be slight or atypical, resulting in a delayed diagnosis. In general, the treatment of older individuals with peptic ulcer or GERD and its complications is similar to that of younger individuals. Proton pump inhibitors are the basis of therapy for symptom relief, healing of erosive esophagitis and peptic ulceration, reduction of the risk for NSAID induced mucosal damage, and prevention of disease relapses. The strongest prevalence of H.pylori infection in the elderly, as well as the role of H.pylori in the occurrence of gastric lesions, in particular ulcer diseases, gastric precancerous lesions and gastric cancer, make the diagnosis and the eradication of H.pylori in this population of the utmost importance. Strategies to improve the management of upper gastrointestinal diseases in older people will reduce mortality and improve quality of life.",
keywords = "elderly, gastroesophageal reflux disease, Helicobacter pylori, peptic ulcer, therapy",
author = "Marilisa Franceschi and {Di Mario}, Francesco and Gioacchino Leandro and Stefania Maggi and Alberto Pilotto",
year = "2009",
month = "12",
doi = "10.1016/j.bpg.2009.10.004",
language = "English",
volume = "23",
pages = "839--848",
journal = "Bailliere's Best Practice and Research in Clinical Gastroenterology",
issn = "1521-6918",
publisher = "Bailliere Tindall Ltd",
number = "6",

}

TY - JOUR

T1 - Acid-related disorders in the elderly

AU - Franceschi, Marilisa

AU - Di Mario, Francesco

AU - Leandro, Gioacchino

AU - Maggi, Stefania

AU - Pilotto, Alberto

PY - 2009/12

Y1 - 2009/12

N2 - Diseases of the upper gastrointestinal tract such as gastroesophageal reflux disease (GERD), peptic ulcer and gastric cancer become more common and more severe with advancing age. Older individuals also tend to have a higher prevalence of co-morbid factors, such as Helicobacter pylori infection, presence of other diseases, or use of medications (e.g., nonsteroidal anti-inflammatory drugs, bisphosphonates) that increase their risk for acid-related disorders. Unfortunately, in the elderly patient with these disorders symptom presentation may be slight or atypical, resulting in a delayed diagnosis. In general, the treatment of older individuals with peptic ulcer or GERD and its complications is similar to that of younger individuals. Proton pump inhibitors are the basis of therapy for symptom relief, healing of erosive esophagitis and peptic ulceration, reduction of the risk for NSAID induced mucosal damage, and prevention of disease relapses. The strongest prevalence of H.pylori infection in the elderly, as well as the role of H.pylori in the occurrence of gastric lesions, in particular ulcer diseases, gastric precancerous lesions and gastric cancer, make the diagnosis and the eradication of H.pylori in this population of the utmost importance. Strategies to improve the management of upper gastrointestinal diseases in older people will reduce mortality and improve quality of life.

AB - Diseases of the upper gastrointestinal tract such as gastroesophageal reflux disease (GERD), peptic ulcer and gastric cancer become more common and more severe with advancing age. Older individuals also tend to have a higher prevalence of co-morbid factors, such as Helicobacter pylori infection, presence of other diseases, or use of medications (e.g., nonsteroidal anti-inflammatory drugs, bisphosphonates) that increase their risk for acid-related disorders. Unfortunately, in the elderly patient with these disorders symptom presentation may be slight or atypical, resulting in a delayed diagnosis. In general, the treatment of older individuals with peptic ulcer or GERD and its complications is similar to that of younger individuals. Proton pump inhibitors are the basis of therapy for symptom relief, healing of erosive esophagitis and peptic ulceration, reduction of the risk for NSAID induced mucosal damage, and prevention of disease relapses. The strongest prevalence of H.pylori infection in the elderly, as well as the role of H.pylori in the occurrence of gastric lesions, in particular ulcer diseases, gastric precancerous lesions and gastric cancer, make the diagnosis and the eradication of H.pylori in this population of the utmost importance. Strategies to improve the management of upper gastrointestinal diseases in older people will reduce mortality and improve quality of life.

KW - elderly

KW - gastroesophageal reflux disease

KW - Helicobacter pylori

KW - peptic ulcer

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=72149108473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149108473&partnerID=8YFLogxK

U2 - 10.1016/j.bpg.2009.10.004

DO - 10.1016/j.bpg.2009.10.004

M3 - Article

VL - 23

SP - 839

EP - 848

JO - Bailliere's Best Practice and Research in Clinical Gastroenterology

JF - Bailliere's Best Practice and Research in Clinical Gastroenterology

SN - 1521-6918

IS - 6

ER -